SC
TENX icon

Steven Cohen’s Tenax Therapeutics TENX Stock Holding History

Steven Cohen’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.1M Buy
556,761
+22,796
+4% +$291K 0.01% 1417
2026
Q1 		$8.54M Buy
533,965
+110,550
+26% +$1.5M 0.01% 1352
2025
Q4 		$5.16M Buy
+423,415
New +$3.68M 0.01% 1827
2017
Q1 		– Sell
-16
Closed -$975K – 958
2016
Q4 		$975K Buy
+16
New +$939K 0.01% 607

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Steven Cohen's TENX Position: Q2 2026 in Review

Steven Cohen increased its Tenax Therapeutics (TENX) stake by 4.3% in Q2 2026, buying an estimated $291K and bringing the position to 556,761 shares worth $8.1M. The position accounts for 0.01% of the portfolio, ranked #1417.

Steven Cohen first reported a position in TENX in Q4 2016 and has held it in 4 quarters since. The position peaked at $8.54M in Q1 2026. 110 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Steven Cohen held 556,761 shares of Tenax Therapeutics worth $8.1M as of Q2 2026.
  • Steven Cohen bought 22,796 Tenax Therapeutics shares in Q2 2026, an estimated $291K.
  • Tenax Therapeutics made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1417 holding.
  • Steven Cohen first reported a position in Tenax Therapeutics in Q4 2016 and has held it in 4 quarters since.
  • Steven Cohen's Tenax Therapeutics position peaked at $8.54M in Q1 2026.
  • 110 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.